drugset / Trial / NCT00209677
Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Phase 1/2
Suspended
40 enrolled
Hokkaido Gastrointestinal Cancer Study Group
Hokkaido University Hospital · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To assess the usefulness of Gemcitabine plus S-1 therapy based on the antitumor effect and survival period. By performing a phase I/II study of this combination in patients with inoperable or with postoperative pancreatic cancer.
Timeline
- Start
- 2004-12
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | S-1 | Small molecule | — | — |